You are here

BOEHRINGER INGELHEIM

BOEHRINGER INGELHEIM

Corporate

https://www.boehringer-ingelheim.fr/

About

Improving the health and quality of life of patients is the goal of the research-driven pharmaceutical company Boehringer lngelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients' lives. In animal health, Boehringer lngelheim stands for advanced prevention. Family-owned since it was established in 1885, Boehringer lngelheim is one of the pharmaceutical industry's top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals. In 2017, Boehringer lngelheim achieved net sales of around 18.1 billion euros. R&D expenditure, exceeding three billion euros, corresponded to 17.0 per cent of net sales. As a family-owned company, Boehringer lngelheim plans in generations and focuses on long-term success, rather than short-term profit. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer lngelheim naturally adopts responsibility towards mankind and the environment.

Type of Organization

Corporate

Address

29 avenue Tony Garnier
69007 LYON

Year founded

1885

Theme

Management contact

Mr. Eric LAMBERT

Minalogic member since

11/2018

ADMIN titre des projets de la fiche membre (porteur) EN

Project lead on

Projet page membre (porteur) EN

No project

ADMIN titre des projets de la fiche membre EN

Project partner on

Projet page membre EN

No project

ADMIN titre des actualités de la fiche membre EN

News

Actualités des membres page membre

No news